A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study

A Clinical Study to Evaluate Ambulatory Counterpulsation for the Treatment of Advanced Heart Failure: A Feasibility Study
Recruiting
18 years - 99 years
Female
Phase N/A
2 Locations

Brief description of study

The purpose of this study is to: assess if the iVAS can help improve blood circulation, gain a better understanding of how this device could impact your health, determine human interaction with the device, and assess the portability of this device.

Detailed description of study

You are being asked to participate because your physician has determined that you have advanced heart failure and require additional circulatory support. Your heart failure has progressed and the damage to your heart is preventing it from sufficiently pumping blood to the rest of your body. Your physician has determined that guideline directed medical therapy for your advanced heart failure is not working and that you may benefit from additional mechanical circulatory support with an intra-aortic balloon pump (IABP, which is implanted through a major artery in your body) or with a ventricular assist device (VAD, which is implanted via open heart surgery). IABPs and VADs are the most common devices used to help patients feel better and live longer. The IABP is a sausage shaped balloon that is inserted into your artery and sits in the chest portion of the aorta.  It inflates while the heart relaxes. It acts like an extra heart pump. This helps with circulating blood in your body. The iVAS also has a skin interface device facilitating patient ambulation, which allows for increased mobility. This study will evaluate a device called the NuPulseCV intravascular ventricular assist system (iVAS) that is similar to an IABP. 

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: acne, cardiology, heart failure
  • Age: 18 years - 99 years
  • Gender: Female

Inclusion Criteria:
Exclusion Criteria:

Updated on 19 Feb 2024. Study ID: TX833374

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Race
Ethnicity
Other language

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.